Relationships between PON1 Q192R polymorphism and clinical outcome of antiplatelet treatment after percutaneous coronary intervention: a meta-analysis.

about

Phenotype distribution of the paraoxonase gene in patients with cardiac disease.

P2860

Q41015173-C44273E5-3916-4241-9E29-69444AFE7986

P2860

Relationships between PON1 Q192R polymorphism and clinical outcome of antiplatelet treatment after percutaneous coronary intervention: a meta-analysis.

Item

http://www.wikidata.org/entity/Q48851836

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Relationships between PON1 Q19 ...... intervention: a meta-analysis.

@en

Relationships between PON1 Q19 ...... intervention: a meta-analysis.

@nl

type

Item

label

Relationships between PON1 Q19 ...... intervention: a meta-analysis.

@en

Relationships between PON1 Q19 ...... intervention: a meta-analysis.

@nl

prefLabel

Relationships between PON1 Q19 ...... intervention: a meta-analysis.

@en

Relationships between PON1 Q19 ...... intervention: a meta-analysis.

@nl

P1476

Relationships between PON1 Q19 ...... intervention: a meta-analysis.

@en

P2093

A-Jing Xu

http://www.w3.org/2001/XMLSchema#string

Jian Zhang

http://www.w3.org/2001/XMLSchema#string

Li-Xia Li

http://www.w3.org/2001/XMLSchema#string

Ping Li

http://www.w3.org/2001/XMLSchema#string

Shu-Hong Bu

http://www.w3.org/2001/XMLSchema#string

Xiao-Tong Lu

http://www.w3.org/2001/XMLSchema#string

Yue-Nian Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Clopidogrel: a review of its use in the prevention of thrombosis

Paraoxonase, a cardioprotective enzyme: continuing issues

Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity

Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCI

Comparison of two methods to detect publication bias in meta-analysis

Structure and stereochemistry of the active metabolite of clopidogrel.

Paraoxonase-1 is not a major determinant of stent thrombosis in a Taiwanese population

Paraoxonase 1 (PON1) gene variants are not associated with clopidogrel response.

P2888

s11033-014-3509-7

P304

6263-6273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11033-014-3509-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263585205

http://www.w3.org/2001/XMLSchema#string

P698

24981930

http://www.w3.org/2001/XMLSchema#string

Relationships between PON1 Q192R polymorphism and clinical outcome of antiplatelet treatment after percutaneous coronary intervention: a meta-analysis.

about

P2860

P2860

Relationships between PON1 Q192R polymorphism and clinical outcome of antiplatelet treatment after percutaneous coronary intervention: a meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698